Clinical Trials · NCT00283062
Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Sanofi
- Enrollment
- 228
- Start date
- Dec 2005
- Locations
- 17 sites, 17 countries
- Primary endpoint
- Progression-free Survival (PFS) Assessment - Number of Participants With Disease Progression